Midgard Science

Labs / Assays & in vitro testing

Nuvisan

Neu-Ulm, Germany · nuvisan.com

GMP

Nuvisan is a CRO/CDMO that supports drug discovery, preclinical, clinical, and CMC development for pharmaceutical and biotechnology clients, as well as research institutions and the veterinary industry. It operates from locations in Germany and France, and also connects chemistry services with a synthesis lab in Hyderabad, India. It works across small and large molecules and multiple therapeutic modalities.

They take quote requests by email.

What they offer

  • Discovery services

    Supports target understanding, target identification and validation, omics and biomarkers, biosciences, compound screening, pharmacology, chemistry, and discovery DMPK.

  • Preclinical development

    Supports preclinical candidate development with DMPK and preclinical safety services.

  • Clinical services phase 1 & 2

    Provides phase 1–2 clinical trial support including clinical pharmacology unit studies, multicentre patient studies, clinical operations, data management, biostatistics, drug safety, consulting, and clinical laboratory services.

  • Clinical trial supply services

    Provides investigational medicinal product manufacturing, packaging and labelling, logistics, storage, distribution, return and destruction, comparator sourcing, direct-to-patient shipments, compassionate use, expanded access, and controlled drug handling.

  • Pharmaceutical analytical services

    Provides analytical support for small and large molecules, including method development and validation, quality control, stability studies, EU re-testing, and commercial release.

  • Drug substances

    Supports drug substance development and related CMC work within integrated solutions.

  • Drug products

    Supports drug product development and related CMC work within integrated solutions.

  • Bioanalysis

    Provides bioanalytical support in preclinical and clinical development.

  • Biomarkers

    Provides biomarker services within discovery and clinical workflows.

  • Digital science technologies

    Provides an integrated digital platform including electronic lab notebook, LIMS, compound registration, assay data management, and reporting tools.

What they work on

Modalities
Small molecule, Antibody, ADC, Peptide, Gene editing, Vaccine, Biosimilar
Species and models
tumour-bearing animal models, in vivo models
Assays and studies
high-throughput screening, fragment screening, virtual screening, biophysical analyses, structure-based design, CRISPR/Cas9, RNA interference, single-cell sequencing, bioanalysis, method development, method validation, quality control, and 3 more
Instruments and platforms
electronic lab notebook, LIMS
Scale and capacity
more than 5.000 m² GMP facilities, more than 320 m² of stability storage, six full-time qualified persons
Therapeutic areas
oncology, dermatology
What to send
sample barcoding
Type
CRDMO
Sites
Neu-Ulm, Germany · Berlin, Germany · Sophia Antipolis, France · Grafing, Germany · Waltrop, Germany · Hyderabad, India
Team
more than 100 analytical experts across Europe
Quality
GMP (laboratories, manufacturing, packaging, release, and clinical trial supply activities) · GLP (laboratories) · ICH/VICH guidelines (QC testing) · EU-GDPR (digital platform) · NIST standards (digital platform) · EU GMP (market authorisation case study) · GCP (early clinical trials) · GDP (clinical trial supply)
Serves
Europe, worldwide
Address
Wegenerstrasse 13 89231 Neu-Ulm Germany Berlin Muellerstrasse 178 13353 Berli

Public records

Ownership
Nuvisan ICB GmbH · DE GLEIF
FDA establishment
3002809479
FDA drug establishment
NUVISAN GmbH source
FDA drug establishment registration
3002809479 · ANALYSIS source

Similar labs. Pacific BioLabs, HitGen, Laxai Life Science, Aurigene Pharmaceutical Services

Found in a contract services directory. Listing built from nuvisan.com. Work here? Claim this listing.

Nuvisan · Midgard Science